Pharmacokinetics and Metabolism of ARV‐393, a BCL6 PROTAC Degrader, in Dogs by UPLC–MS/MS and UPLC‐Q‐Exactive Orbitrap‐HRMS

Documenti analoghi

• Metabolic Stability and Comprehensive Metabolite Profiling of Chrysotobibenzyl in Human Liver Microsomes and Hepatocytes Employing UPLC‐MS/MS and UPLC‐Orbitrap‐HRMS Analysis
  di: Xuanwei Liu, et al.
  Pubblicazione: (2025)
• Pharmacokinetic and Metabolism Study of Ginkgolide C in Rats by UPLC‐Q‐TOF‐MS and UPLC‐MS/MS
  di: Yanling Hao, et al.
  Pubblicazione: (2025)
• Identification and Multidimensional Evaluation of Quality Markers in Yupingfeng via UPLC‐Q‐Orbitrap‐MS, Network Pharmacology, UPLC‐UV Fingerprint, and UPLC‐QQQ‐MS
  di: Shu Li, et al.
  Pubblicazione: (2026)
• Integrated Characterization and Pharmacokinetics of Kanli Granule in Rats Based on UPLC‐Q‐TOF‐MS/MS: In Vitro and In Vivo Component Screening
  di: Xuehao Cheng, et al.
  Pubblicazione: (2026)
• Establishment of UPLC‐MS/MS Method for Determining the Content of Memantine in Rat Plasma and Its Pharmacokinetic Differences at Different Altitudes
  di: Jinwen Wang, et al.
  Pubblicazione: (2025)